-transparent.png){kind=logo}
The inclusion behavior of methylated beta-cyclodextrins, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and heptakis-(2,3,6-tri-O-methyl)-beta-cyclodextrin in solution and the solid state was compared with that of natural beta-cyclodextrin using an anti-inflammatory drug, flurbiprofen, as a guest molecule. Stability constants were determined by the solubility method at various temperatures, and the thermodynamic parameters were calculated for inclusion complex formation in aqueous solution. The solid complexes were obtained in a molar ratio of 1:1, and their dissolution behavior and release from suppository bases were examined. The data suggest that the inclusion mode of the complex with 3 is somewhat different from that of the complexes with 1 and 2. From a practical point of view, 2 seems to be particularly useful for improving the pharmaceutical properties of flurbiprofen in various dosage forms.
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
May 1989,
Journal of pharmaceutical sciences,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
August 1995,
Journal of pharmaceutical sciences,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
December 1993,
The Journal of pharmacy and pharmacology,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
January 2009,
Natural product research,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
April 2008,
Chemical & pharmaceutical bulletin,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
January 2007,
Rapid communications in mass spectrometry : RCM,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
November 1992,
The Journal of antibiotics,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
February 1991,
Journal of pharmaceutical sciences,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
October 1999,
Journal of pharmaceutical sciences,
K Uekama, and
T Imai, and
T Maeda, and
T Irie, and
F Hirayama, and
M Otagiri
October 1994,
Journal of pharmaceutical and biomedical analysis,
